Immune responses of patients without cancer recurrence after a cancer vaccine over a long term-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune responses of patients without cancer recurrence after a cancer vaccine over a long term

Published:2022-05-13 Issue:6 Volume:16 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Suekane Shigetaka¹,Yutani Shigeru²,Toh Uhi³,Yoshiyama Koichi³,Itoh Kyogo²

Affiliation:

1. Department of Urology, Kurume University School of Medicine, Kurume, Fukuoka 830‑0011, Japan

2. Kurume Cancer Vaccine Center, Kurume University, Kurume, Fukuoka 830‑0011, Japan

3. Department of Surgery, Kurume University School of Medicine, Kurume, Fukuoka 830‑0011, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference25 articles.

1. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): A randomised, double-blind, placebo-controlled, phase 3 trial;Vansteenkiste;Lancet Oncol,2016

2. Colorectal cancer immunotherapy;Xiang;Discov Med,2013

3. Efficacy and safety analysis of Nelipepimut-S vaccine to prevent breast cancer recurrence: A randomized, multicenter, phase III clinical trial;Mittendorf;Clin Cancer Res,2019

4. Results of a randomized phase IIb trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to prevent recurrences in patients with high-risk HER2 low-expressing breast cancer;Clifton;Clin Cancer Res,2020

5. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N Engl J Med,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Potential of Humoral Immune Response to Commensal Bifidobacterium as a Biomarker for Human Health, including Both Malignant and Non-Malignant Diseases: A Perspective on Detection Strategies and Future Directions;Biomedicines;2024-04-04

2. Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults;2023-06-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3